- Home
- LNTH vs HCP Comparison
LNTH vs HCP Comparison
Compare LNTH & HCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- HCP
- Stock Information
- Founded
- LNTH 1956
- HCP 2012
- Country
- LNTH United States
- HCP United States
- Employees
- LNTH N/A
- HCP N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HCP EDP Services
- Sector
- LNTH Health Care
- HCP Technology
- Exchange
- LNTH Nasdaq
- HCP Nasdaq
- Market Cap
- LNTH 6.3B
- HCP 7.0B
- IPO Year
- LNTH 2015
- HCP 2021
- Fundamental
- Price
- LNTH $94.05
- HCP $34.28
- Analyst Decision
- LNTH Strong Buy
- HCP Hold
- Analyst Count
- LNTH 6
- HCP 14
- Target Price
- LNTH $132.67
- HCP $32.80
- AVG Volume (30 Days)
- LNTH 723.3K
- HCP 2.2M
- Earning Date
- LNTH 02-20-2025
- HCP 03-04-2025
- Dividend Yield
- LNTH N/A
- HCP N/A
- EPS Growth
- LNTH 304.57
- HCP N/A
- EPS
- LNTH 6.02
- HCP N/A
- Revenue
- LNTH $1,496,799,000.00
- HCP $654,890,000.00
- Revenue This Year
- LNTH $19.64
- HCP $17.07
- Revenue Next Year
- LNTH $5.16
- HCP $12.69
- P/E Ratio
- LNTH $15.62
- HCP N/A
- Revenue Growth
- LNTH 24.15
- HCP 16.29
- 52 Week Low
- LNTH $50.20
- HCP $21.50
- 52 Week High
- LNTH $126.89
- HCP $34.47
- Technical
- Relative Strength Index (RSI)
- LNTH 53.53
- HCP 57.24
- Support Level
- LNTH $89.92
- HCP $34.15
- Resistance Level
- LNTH $97.25
- HCP $34.37
- Average True Range (ATR)
- LNTH 3.42
- HCP 0.15
- MACD
- LNTH 0.05
- HCP -0.01
- Stochastic Oscillator
- LNTH 67.86
- HCP 54.76
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About HCP HashiCorp Inc.
HashiCorp Inc is engaged in solving the infrastructure challenges of cloud adoption by enabling an operating model that unlocks the full potential of modern public and private clouds. Its cloud operating model provides consistent workflows and a standardized approach to automate the processes involved in delivering applications in the cloud: infrastructure provisioning, security, networking, and application deployment. Its main commercial products are Terraform, Vault, Consul, and Nomad.